|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 108, Issue 6 2197-2204, Copyright © 1995 by Company of Biologists
JOURNAL ARTICLES |
JG Tidball, DE Albrecht, BE Lokensgard and MJ Spencer
Department of Physiological Science, University of California, Los Angeles 90024-1527, USA.
The current view that death of dystrophin-deficient muscle fibers is a necrotic process relies primarily upon the histological appearance of the tissue after the degenerative process is well advanced. Here, we tested this view by examining the possibility that apoptosis is a component of dystrophin-deficient muscle cell death. Three assays for apoptosis were employed in analyzing prenecrotic, peak necrotic and regenerated hindlimb muscle of mdx mice: (1) terminal deoxynucleotidyl transferase (TdT) mediated end-labeling of DNA in nuclei in tissue sections; (2) assays for DNA ladders; and (3) electron microscopic assays for the presence of organelles undergoing structural changes characteristic of apoptosis. At all ages sampled, mdx muscle contained apoptotic nuclei, according to TdT-mediated dUTP labeling of tissue sections. Nuclei in regenerated mdx muscle fibers did not display apoptosis. dUTP-labeled nuclei in control C57 muscles were rare or absent at all ages sampled. DNA from 4-week-old mdx mice was found to be cleaved into fragments indicative of preferential cleavage at internucleosomal sites. Electron microscopic analysis showed that organelle structural changes indicating apoptosis appear before pathological changes diagnostic of necrosis. For example, condensed mitochondria, fragmented sarcoplasmic reticulum and nuclei with chromatin condensations resembling apoptosis appear in fibers that otherwise possess normal morphology. Together, the findings show that apoptosis precedes any detectable necrotic change in mdx muscle, and that apoptotic events continue into the stage of dystrophic pathology that is currently viewed as necrosis. Thus, apoptosis characterizes the onset of pathology in dystrophin-deficient muscle which is followed secondarily by necrotic processes.
This article has been cited by other articles:
|
|
 |
|
  J. E. Davies, S. Sarkar, and D. C. Rubinsztein Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation Hum. Mol. Genet., April 15, 2008; 17(8): 1097 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Jung, A. S. Martins, E. Niggli, and N. Shirokova Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways Cardiovasc Res, March 1, 2008; 77(4): 766 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Peter, G. Miller, and R. H. Crosbie Disrupted mechanical stability of the dystrophin-glycoprotein complex causes severe muscular dystrophy in sarcospan transgenic mice J. Cell Sci., March 15, 2007; 120(6): 996 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sonnet, P. Lafuste, L. Arnold, M. Brigitte, F. Poron, F. Authier, F. Chretien, R. K. Gherardi, and B. Chazaud Human macrophages rescue myoblasts and myotubes from apoptosis through a set of adhesion molecular systems J. Cell Sci., June 15, 2006; 119(12): 2497 - 2507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Rooney, J. V. Welser, M. A. Dechert, N. L. Flintoff-Dye, S. J. Kaufman, and D. J. Burkin Severe muscular dystrophy in mice that lack dystrophin and {alpha}7 integrin J. Cell Sci., June 1, 2006; 119(11): 2185 - 2195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Guo, M. Willem, A. Werner, G. Raivich, M. Emerson, L. Neyses, and U. Mayer Absence of {alpha}7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy Hum. Mol. Genet., March 15, 2006; 15(6): 989 - 998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Dominov, A. J. Kravetz, M. Ardelt, C. A. Kostek, M. L. Beermann, and J. B. Miller Muscle-specific BCL2 expression ameliorates muscle disease in laminin {alpha}2-deficient, but not in dystrophin-deficient, mice Hum. Mol. Genet., April 15, 2005; 14(8): 1029 - 1040. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Kramerova, E. Kudryashova, J.G. Tidball, and M. J. Spencer Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro Hum. Mol. Genet., July 1, 2004; 13(13): 1373 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hino, K. Araki, E. Uyama, M. Takeya, M. Araki, K. Yoshinobu, K. Miike, Y. Kawazoe, Y. Maeda, M. Uchino, et al. Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy Hum. Mol. Genet., January 15, 2004; 13(2): 181 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Abmayr, R.W. Crawford, and J.S. Chamberlain Characterization of ARC, apoptosis repressor interacting with CARD, in normal and dystrophin-deficient skeletal muscle Hum. Mol. Genet., January 15, 2004; 13(2): 213 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. KUMAR, N. KHANDELWAL, R. MALYA, M. B. REID, and A. M. BORIEK Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers FASEB J, January 1, 2004; 18(1): 102 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. KUMAR and A. M. BORIEK Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy FASEB J, March 1, 2003; 17(3): 386 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Spencer and R. L. Mellgren Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology Hum. Mol. Genet., October 2, 2002; 11(21): 2645 - 2655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Spencer, J. R. Guyon, H. Sorimachi, A. Potts, I. Richard, M. Herasse, J. Chamberlain, I. Dalkilic, L. M. Kunkel, and J. S. Beckmann Stable expression of calpain 3 from a muscle transgene in vivo: Immature muscle in transgenic mice suggests a role for calpain 3 in muscle maturation PNAS, June 25, 2002; 99(13): 8874 - 8879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Mozdziak, J. J. Evans, and D. W. McCoy Early Posthatch Starvation Induces Myonuclear Apoptosis in Chickens J. Nutr., May 1, 2002; 132(5): 901 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Blake, A. Weir, S. E. Newey, and K. E. Davies Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle Physiol Rev, April 1, 2002; 82(2): 291 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kamogawa, S. Biro, M. Maeda, M. Setoguchi, T. Hirakawa, H. Yoshida, and C. Tei Dystrophin-deficient myocardium is vulnerable to pressure overload in vivo Cardiovasc Res, June 1, 2001; 50(3): 509 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Stupka, S. Lowther, K. Chorneyko, J. M. Bourgeois, C. Hogben, and M. A. Tarnopolsky Gender differences in muscle inflammation after eccentric exercise J Appl Physiol, December 1, 2000; 89(6): 2325 - 2332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Berchtold, H. Brinkmeier, and M. Muntener Calcium Ion in Skeletal Muscle: Its Crucial Role for Muscle Function, Plasticity, and Disease Physiol Rev, July 1, 2000; 80(3): 1215 - 1265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Rando, M.-H. Disatnik, and L. Z.-H. Zhou Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotides PNAS, May 9, 2000; 97(10): 5363 - 5368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ikeda, M. Martone, Y. Gu, M. Hoshijima, A. Thor, S. S. Oh, K. L. Peterson, and J. Ross Jr. Altered membrane proteins and permeability correlate with cardiac dysfunction in cardiomyopathic hamsters Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1362 - H1370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Montanaro, M. Lindenbaum, and S. Carbonetto alpha -Dystroglycan Is a Laminin Receptor Involved in Extracellular Matrix Assembly on Myotubes and Muscle Cell Viability J. Cell Biol., June 14, 1999; 145(6): 1325 - 1340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chinni, M. R. de Niese, D. J. Tew, A. L. Jenkins, S. P. Bottomley, and E. J. Mackie Thrombin, a Survival Factor for Cultured Myoblasts J. Biol. Chem., April 2, 1999; 274(14): 9169 - 9174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Taverna, M.-H. Disatnik, H. Rayburn, R. T. Bronson, J. Yang, T. A. Rando, and R. O. Hynes Dystrophic Muscle in Mice Chimeric for Expression of alpha 5 Integrin J. Cell Biol., November 2, 1998; 143(3): 849 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Dominov, J. J. Dunn, and J. B. Miller Bcl-2 Expression Identifies an Early Stage of Myogenesis and Promotes Clonal Expansion of Muscle Cells J. Cell Biol., July 27, 1998; 142(2): 537 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Koseki, N. Inohara, S. Chen, and G. Nunez ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases PNAS, April 28, 1998; 95(9): 5156 - 5160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Endo and B Nadal-Ginard Reversal of myogenic terminal differentiation by SV40 large T antigen results in mitosis and apoptosis J. Cell Sci., January 4, 1998; 111(8): 1081 - 1093. [Abstract] [PDF]
|
|
|
|
|
|
M. Mancini, B. O. Anderson, E. Caldwell, M. Sedghinasab, P. B. Paty, and D. M. Hockenbery Mitochondrial Proliferation and Paradoxical Membrane Depolarization during Terminal Differentiation and Apoptosis in a Human Colon Carcinoma Cell Line J. Cell Biol., July 28, 1997; 138(2): 449 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Carbonari, A. M. Pesce, M. Cibati, A. Modica, L. Dell'Anna, G. D'Offizi, A. Angelici, S. Uccini, A. Modesti, and M. Fiorilli Death of Bystander Cells by a Novel Pathway Involving Early Mitochondrial Damage in Human Immunodeficiency Virus-Related Lymphadenopathy Blood, July 1, 1997; 90(1): 209 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Robert, M. L. Massimino, V. Tosello, R. Marsault, M. Cantini, V. Sorrentino, and T. Pozzan Alteration in Calcium Handling at the Subcellular Level in mdx Myotubes J. Biol. Chem., February 9, 2001; 276(7): 4647 - 4651. [Abstract] [Full Text] [PDF]
|
|
